55PDIdentification of biological axes associated with stage II/III CRC recurrence risk and outcome after adjuvant therapy revealed a T-effector-independent prognostic role for granzyme B. - Thakur, M Das; Udyavar, A; Sandmann, T; Li, C; Bosch, L J W; O'Gorman, W; Li, Y; Au-Yeung, A; Takahashi, C; Bourgon, R (Annals of Oncology, 2018)